# Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study

> **NCT02735447** · — · UNKNOWN · sponsor: **La-ser Europe Limited** · enrollment: 190 (estimated)

## Conditions studied

- Sporadic Inclusion Body Myositis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02735447
- **Lead sponsor:** La-ser Europe Limited
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2016-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02735447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02735447, "Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02735447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*